Editorial
Subtyping or not subtyping—Quo vadis for precision medicine of colorectal cancer
Translational Cancer Research
2023;
12
(5)
:1067-1072
.
(31 May 2023)
Original Article
Prognostic significance of carboxypeptidase Q and its methylation in glioblastoma
Translational Cancer Research
2023;
12
(5)
:1073-1087
.
(31 May 2023)
Clinical outcomes of hepatocellular carcinoma patients after hepatectomy treated with TACE in combination with sorafenib: a propensity score matched analysis
Translational Cancer Research
2023;
12
(5)
:1088-1099
.
(31 May 2023)
Identification and validation of a glycolysis-related gene signature for predicting metastasis and survival rate in patients with thyroid cancer
Translational Cancer Research
2023;
12
(5)
:1100-1111
.
(31 May 2023)
Identification of key genes in HER2-positive breast cancer with brain metastasis via bioinformatics methods
Translational Cancer Research
2023;
12
(5)
:1112-1127
.
(31 May 2023)
Surgical resection of primary tumors improves survival in patients with lung metastases: a population-based SEER analysis
Translational Cancer Research
2023;
12
(5)
:1128-1144
.
(31 May 2023)
A novel prognostic biomarker: GINS3 is correlated with methylation and immune escape in liver hepatocellular carcinoma
Translational Cancer Research
2023;
12
(5)
:1145-1164
.
(31 May 2023)
Prognostic model construction and immune microenvironment analysis of esophageal cancer based on gene expression data and microRNA target genes
Translational Cancer Research
2023;
12
(5)
:1165-1174
.
(31 May 2023)
Cuproptosis-related lncRNAs forecast the prognosis of acute myeloid leukemia
Translational Cancer Research
2023;
12
(5)
:1175-1195
.
(31 May 2023)
Identification and validation of an epithelial-mesenchymal transition-related lncRNA pairs prognostic model for gastric cancer
Translational Cancer Research
2023;
12
(5)
:1196-1209
.
(31 May 2023)
Identification of immune-related genes and patient selection for hepatocellular carcinoma immunotherapy
Translational Cancer Research
2023;
12
(5)
:1210-1231
.
(31 May 2023)
Use of machine learning with two-dimensional synthetic mammography for axillary lymph node metastasis prediction in breast cancer: a preliminary study
Translational Cancer Research
2023;
12
(5)
:1232-1240
.
(31 May 2023)
Prognostic value of prior malignancy history in stage I differentiated thyroid cancer: a SEER-based study
Translational Cancer Research
2023;
12
(5)
:1241-1253
.
(31 May 2023)
Construction of diagnostic and prognostic models based on gene signatures of nasopharyngeal carcinoma by machine learning methods
Translational Cancer Research
2023;
12
(5)
:1254-1269
.
(31 May 2023)
Integrated analysis of single-cell and bulk transcriptome identifies a signature based on NK cell marker genes to predict prognosis and therapeutic response in clear cell renal cell carcinoma
Translational Cancer Research
2023;
12
(5)
:1270-1289
.
(31 May 2023)
LINC00638/hsa-miR-29b-3p axis-mediated high expression of CDCA4 correlates with tumor immune infiltration and hepatocellular carcinoma progression
Translational Cancer Research
2023;
12
(5)
:1290-1306
.
(31 May 2023)
Identifying the risk factors and developing a predictive model for postoperative pelvic floor dysfunction in cervical cancer patients
Translational Cancer Research
2023;
12
(5)
:1307-1314
.
(31 May 2023)
Clinicopathological and prognosis significance of RIPK1 in patients with cervical squamous cell carcinoma: a retrospective cohort study
Translational Cancer Research
2023;
12
(5)
:1315-1324
.
(31 May 2023)
Case Series
Clinical features and surgical outcomes of primary spinal anaplastic meningioma: a cases series and literature review
Translational Cancer Research
2023;
12
(5)
:1325-1334
.
(31 May 2023)
Review Article
Recent advances and challenges in primary central nervous system lymphoma: a narrative review
Translational Cancer Research
2023;
12
(5)
:1335-1352
.
(31 May 2023)
Editorial Commentary
Evolving treatment paradigms in recurrent and metastatic head and neck squamous cell carcinoma: the emergence of immunotherapy
Translational Cancer Research
2023;
12
(5)
:1353-1358
.
(31 May 2023)
The potential of microRNA carried by small extracellular vesicles in cancer plasma to serve as cancer biomarkers
Translational Cancer Research
2023;
12
(5)
:1359-1362
.
(31 May 2023)
Long-term efficacy of immune checkpoint inhibitors with or without chemotherapy in recurrent or metastatic squamous cell carcinoma of the head and neck: a commentary on the 4-year follow-up of the KEYNOTE-048 trial
Translational Cancer Research
2023;
12
(5)
:1363-1367
.
(31 May 2023)
Multiomic characterization of high-grade serous ovarian carcinoma: editorial commentary on recent application and consideration for future directions
Translational Cancer Research
2023;
12
(5)
:1368-1371
.
(31 May 2023)
Erratum
Erratum to miR-3614-3p suppresses cell aggressiveness of human breast cancer by targeting AKT3 and HDAC1 expression
Translational Cancer Research
2023;
12
(5)
:1372-1375
.
(31 May 2023)
